Executives On The Move: Exits From Blueprint Medicines And Aerpio Pharma To CMO Posts, Plus Sales Leader Departs Seattle Genetics
Executive Summary
SVP exits precision med firm Blueprint Medicines for CMO post at KSQ Therapeutics and a CMO switches from Aerpio Pharma to gene therapy developer Regenxbio. Seattle Genetics EVP departs for top commercial post at GW Pharmaceuticals.